Trust and Use of Recommendations for Health Apps Among European Residents: Cross-Sectional Survey
Clinical Snapshot
PICO Framework
| P — Population | European residents from 33 countries (N=1228) who completed an online survey |
| I — Intervention | Not applicable (observational study) |
| C — Comparator | Different sources of health app recommendations (health professionals vs family/friends vs government authorities) |
| O — Outcomes | Trust levels in different recommendation sources, usage patterns of health apps, support for government review and rating systems |
Bottom Line
This large European survey reveals a significant gap between trusted and used sources for health app recommendations. While 80% of respondents trust health professionals' advice, only 34% actually seek it, instead relying on family and friends (35%). The findings strongly support government-led app review systems (86% approval) and highlight an opportunity for healthcare professionals to bridge this trust-usage gap. For Australian practice, this reinforces the importance of the TGA's medical device app framework and suggests patients would welcome professional guidance on app selection. Healthcare providers should proactively discuss app recommendations, particularly given high trust levels in both doctors (80%) and pharmacists (61%). The study's methodology is sound but limited by online sampling bias and lack of confidence intervals.
Key Findings
P Value: Multiple comparisons adjusted to P<0.004
Effect Size: Health professionals most trusted (80.4%) vs most used source family/friends (35.3%)
Primary Outcome: Trust in health app recommendation sources
Nnt Or Sensitivity: 86.3% support government review and rating systems
Confidence Interval: Not reported
Clinical Application
High - findings support existing digital health initiatives and professional recommendation systems Highly relevant to Australian Digital Health Strategy and TGA medical device app regulations. Supports role of pharmacists and GPs in app recommendations consistent with RACGP digital health guidelines Healthcare consumers using or considering health apps, particularly in developed healthcare systems
Abstract
BACKGROUND: There is growing recognition of the role of health apps in addressing health care system challenges, yet app quality and evidence vary widely, and consumers have little decision support at the point of download. OBJECTIVE: This study aimed to explore which sources of recommendations European residents use and trust when choosing health apps and whether residents support government review and rating of health apps. METHODS: We conducted a cross-sectional online survey (December 7, 2022, to February 16, 2023) in 26 languages targeting residents of the European Economic Area, the United Kingdom, and Ukraine. The survey contained 11 questions covering demographics, types of apps used, sources of advice used and trusted, and views on government review and rating. We included only fully completed responses (N=1228). Descriptive statistics are presented as counts and percentages. For subgroup analyses, we dichotomized trust responses ("I trust" vs other responses) and tested associations with gender (Fisher exact test), age group, and education level (chi-square test); an adjusted significance threshold was applied (P<.004) to account for multiple testing. We followed the CHERRIES (Checklist for Reporting Results of Internet E-Surveys) guidelines for reporting online surveys and STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) recommendations for observational studies. RESULTS: A total of 1228 respondents from 33 countries completed the survey; 1110 (90.4%) reported using one or more health apps. COVID-19 apps (763/1228, 62.1%) and activity apps (737/1228, 60.0%) were the most frequently used, whereas disease management (86/1228, 7.0%), diagnostic (77/1228, 6.3%), and treatment apps (70/1228, 5.7%) were the least used. Sources used to choose apps included family and friends (434/1228, 35.3%), health professionals (412/1228, 33.6%), and government or health authorities (358/1228, 29.2%). The most trusted sources were health professionals (987/1228, 80.4%), pharmacists (750/1228, 61.1%), and government or health authorities (736/1228, 59.9%). No statistically significant differences in trust by gender were observed (all P>.0038). Some differences by age and education were observed for select sources (eg, government or health authorities: χ21=8.546; P=.003; family and friends: χ2=19.133; P<.001). Overall, 1060 (86.3%) of 1228 respondents supported government review and rating of health apps (either directly or by commissioning another organization). CONCLUSIONS: In this large multilingual European survey, most respondents reported experience with health apps and placed greatest trust in health professionals, pharmacists, and government or health authorities, yet professional recommendations were used less often than informal sources. There is clear public support for government-led review and rating schemes to guide consumer choice. Efforts to make trustworthy, easy-to-find information available at the point of download and to support health care professionals in recommending high-quality apps could help bridge the gap between trusted and used sources.
References
- 1.Shokralla, M., Willemsen, R. F., Kasteleyn, M. J., Chavannes, N., & Talboom-Kamp, E. (2026). Trust and Use of Recommendations for Health Apps Among European Residents: Cross-Sectional Survey. JMIR mHealth and uHealth. https://doi.org/10.2196/64468
Related Research
The Journal of rheumatology
Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review
3 Aug 2026
Acta obstetricia et gynecologica Scandinavica
ChatGPT in urogynecology: Comparing large language model responses to human experts
3 Aug 2026
Sleep medicine
Concordance of wearable device sleep metrics with patient-reported sleep quality: A systematic review
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service